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mendations exist for further treatment. OBJECTIVES To summarize treatment efficacy for patients
presenting with NCCP. METHODS Systematic review and meta-analysis. In July 2013, Medline, Web
of Knowledge, Embase, EBSCOhost, Cochrane Reviews and Trials, and Scopus were searched. Hand and
bibliography searches were also conducted. Randomized controlled trials (RCTs) evaluating non-surgical
treatments in patients with NCCP were included. Exclusion criteria were poor study quality and small
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assessed PPI efficacy for gastroesophageal reflux disorders (GERD, n = 10). Two RCTs included mus-
culoskeletal chest pain, seven psychotropic drugs, and eleven various psychological interventions. Study
quality was high in five RCTs and acceptable in 25. PPI treatment in patients with GERD (5 RCTs,
192 patients) was more effective than placebo [pooled OR 11.7 (95% CI 5.5 to 25.0, heterogeneity I2 =
6.1%)]. The pooled OR in GERD negative patients (4 RCTs, 156 patients) was 0.8 (95% CI 0.2 to 2.8,
heterogeneity I2 = 50.4%). In musculoskeletal NCCP (2 RCTs, 229 patients) manual therapy was more
effective than usual care but not than home exercise [pooled mean difference 0.5 (95% CI -0.3 to 1.3, het-
erogeneity I2 = 46.2%)]. The findings for cognitive behavioral treatment, serotonin reuptake inhibitors,
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Abstract
Background: Non-cardiovascular chest pain (NCCP) leads to impaired quality of life and is associated with a high disease
burden. Upon ruling out cardiovascular disease, only vague recommendations exist for further treatment.
Objectives: To summarize treatment efficacy for patients presenting with NCCP.
Methods: Systematic review and meta-analysis. In July 2013, Medline, Web of Knowledge, Embase, EBSCOhost, Cochrane
Reviews and Trials, and Scopus were searched. Hand and bibliography searches were also conducted. Randomized
controlled trials (RCTs) evaluating non-surgical treatments in patients with NCCP were included. Exclusion criteria were poor
study quality and small sample size (,10 patients per group).
Results: Thirty eligible RCT’s were included. Most studies assessed PPI efficacy for gastroesophageal reflux disorders (GERD,
n = 10). Two RCTs included musculoskeletal chest pain, seven psychotropic drugs, and eleven various psychological
interventions. Study quality was high in five RCTs and acceptable in 25. PPI treatment in patients with GERD (5 RCTs, 192
patients) was more effective than placebo [pooled OR 11.7 (95% CI 5.5 to 25.0, heterogeneity I2 = 6.1%)]. The pooled OR in
GERD negative patients (4 RCTs, 156 patients) was 0.8 (95% CI 0.2 to 2.8, heterogeneity I2 = 50.4%). In musculoskeletal NCCP
(2 RCTs, 229 patients) manual therapy was more effective than usual care but not than home exercise [pooled mean
difference 0.5 (95% CI 20.3 to 1.3, heterogeneity I2 = 46.2%)]. The findings for cognitive behavioral treatment, serotonin
reuptake inhibitors, tricyclic antidepressants were mixed. Most evidence was available for cognitive behavioral treatment
interventions.
Limitations: Only a small number of studies were available.
Conclusions: Timely diagnostic evaluation and treatment of the disease underlying NCCP is important. For patients with
suspected GERD, high-dose treatment with PPI is effective. Only limited evidence was available for most prevalent diseases
manifesting with chest pain. In patients with idiopathic NCCP, treatments based on cognitive behavioral principles might be
considered.
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Background
In the United States, 6 million patients present to emergency
departments with chest pain each year, at an annual cost of $8
billion [1,2]. Sixty to ninety percent of the patients that present to
emergency departments with chest pain have no underlying
cardiovascular disease [3–6]. The proportion of patients with
cardiovascular disease is higher in specialized units (cardiology
emergency departments, CCU, ICU) [7] and lower in the primary
care setting [6,8–10]. After serious illnesses have been ruled out,
physicians often assume that patients with non-cardiovascular
chest pain (NCCP) have an excellent prognosis [11,12]. However,
patients with NCCP have a high disease burden; many patients
that seek care for NCCP complain of persisting symptoms in a 4-
year follow-up [13]. Furthermore, patients with non-cardiac chest
pain experience an impaired quality of life and greater number of
medical visits compared with patients with cardiac pain [14].
In patients with chest pain, the diagnostic work-up focuses
primarily on cardiovascular disease and is often performed by
cardiologists. Upon ruling out cardiovascular disease, only vague
recommendations exist for further treatment, delaying appropriate
treatment and causing uncertainty for patients [15]. A recent
systematic synthesis of diagnostic tests [16] showed that patients
with gastroesophageal reflux disorder (GERD) can be identified by
their response to proton pump inhibitor (PPI) treatment, and
certain clinical findings can guide clinicians to the most
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e104722
appropriate treatments (e.g., pain increase with movement or
decrease on medication were associated with musculoskeletal chest
pain). However, limited data are available regarding the efficacy of
treatments for patients with NCCP.
The present systematic review aimed to summarize the current
evidence about the efficacy of different treatments based on
randomized controlled trials (RCTs) for patients that seek care for
NCCP.
Methods
Literature search and study selection
This search, conducted in July 2013, followed the PRISMA
statement [17]. We searched six databases: Medline (OvidSP),
including In-Process & Other Non-Indexed Citations, Daily and
OLDMEDLINE; Web of Knowledge, including Biosis and Web
of Science; Embase (OvidSP); EBSCOhost, including CINAHL
and PsycINFO; Cochrane Reviews and Trials; and Scopus. We
used the following search terms as medical subject headings
(MeSH terms) and other subject headings: ‘thoracic pain’, ‘chest
pain’, ‘non-cardiac chest pain’, ‘atypical chest pain’, ‘musculo-
skeletal chest pain’, ‘esophageal chest pain’, and ‘thoracic spine
pain’. The findings were limited to studies published in the last 20
years. We applied no limits regarding study setting or language.
Table S1 depicts two detailed search strategies.
To ensure search completeness, one reviewer (BJ) conducted a
thorough search of the bibliographies of all included studies.
Potential eligible references were also included in the full text
review.
Eligibility criteria
Eligible studies were randomized controlled trials (RCTs)
published in the last 20 years. Inclusion criteria were studies
reporting on patients aged $18 years seeking care for NCCP.
NCCP was defined as chest pain after cardiac or other vascular
disease (e.g., cardiovascular disease, aortic dissection, pulmonary
embolism) had been ruled out. Studies with less than 10 patients
per group were excluded.
Study selection, data extraction, and synthesis
Two reviewers (MW and BJ) independently screened 5372
references by title and abstract. Both reviewers independently
reviewed the full text of 62 studies that met the eligibility criteria.
Disagreements were discussed and resolved by consensus or third
party arbitration (JS). Researchers with specific language profi-
ciencies reviewed non-English language references. When the
same study was included in several publications without change in
treatment, outcome, or follow-up, the most recent publication was
chosen and missing information was added from previous
publications.
All information regarding the treatment and control groups,
treatment duration, follow-up duration, and patient population
was extracted and grouped according to the disease investigated.
Quality assessment
Study quality was assessed using the Scottish Intercollegiate
Guidelines Network (SIGN) methodology checklist for RCTs [18].
Overall bias risk and study quality were rated according to the
SIGN recommendations. The ratings included high quality (++;
the majority of criteria met; little or no risk of bias; results unlikely
to be changed by further research.), acceptable quality (+; most
criteria met; some flaws in the study with an associated risk of bias;
conclusions may change in the light of further studies), and low
quality (0; either most criteria not met, or significant flaws relating
to key aspects of study design; conclusions likely to change in the
light of further studies).
It was not possible to include all studies in the meta-analysis
because data was missing for some outcomes. It may have
happened that the studies originally considered several different
outcome measures, but only reported the measures that provided
significant results. Copas et al. [19] refer to this as outcome
reporting bias, which is defined as outcome reporting driven by the
significance and/or direction of the effect size. All studies that were
not included in the meta-analyses were assessed for a potential
outcome reporting bias using the 9-item outcome reporting in
trails (ORBIT) tool [20]. Risk of bias was rated from low (outcome
of interest was not measured) to high [trial report states that
outcome was analyzed, but only reports that the result was not
significant (typically stating p.0.05)].
Outcome
The outcome of primary interest was chest pain, including chest
pain frequency and intensity.
We also assessed psychological outcome measures. In particular,
we aimed to assess the efficacy of treatment interventions on
anxiety, depression, and panic disorders. All measures were
extracted, and validity of the outcome measure used was assessed.
Statistical analysis
Descriptive statistics were used to summarize findings across all
groups of diagnostic studies. These included number of patients,
mean patient age, and gender distribution.
In order to summarize findings across studies, different pain
score scales were re-scaled to a 0- to 10-point scale where
necessary. In addition, the frequency scores were homogenized to
present results on a monthly basis. To present counted pain events
in the treatment and control arms as odds ratios, we used number
of events and number of patients in both groups, with a cut-off of
.50% improvement. To present changes from baseline to follow-
up in the treatment and control arms as mean differences, we used
mean change, standard deviation of change, and number of
patients in both groups. If the necessary information was not
directly available from the original publication, we derived these
quantities following instructions described in the Cochrane
Handbook [21]. We assumed a random effects model to obtain
a pooled estimate of the effect if more than one trial was available
in a subgroup. A restricted maximum-likelihood estimator was
used to quantify the amount of heterogeneity.
Risk of bias was assessed using a funnel plot. Funnel plot
asymmetry was assessed with the regression test proposed by Egger
[22].




Figure 1 summarizes the search and inclusion process. Out of
5372 records, 62 were reviewed in full text, resulting in the
exclusion of 5310 studies. In total, the analysis included 32
publications based on 30 RCTs. Reasons for the exclusion of 30
publications are provided in Figure 1.
Study characteristics
Table 1 presents the study characteristics and included patients.
Ten RCTs (33%) included patients with underlying gastrointes-
tinal cause. Most RCTs (n= 8, 1037 patients) evaluated the
treatment efficacy of a PPI in patients with NCCP [25–32]. Other
Treatment Efficacy for Non-Cardiovascular Chest Pain
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Figure 1. Study flow.
doi:10.1371/journal.pone.0104722.g001
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treatments included baclofen [33] and hypnotherapy [34]. Two
RCTs included patients with musculoskeletal chest pain (7%, 229
patients): one compared the efficacy of manual therapy to
acupuncture and sham intervention [35], while the other
compared chiropractic treatment to self-management [36,37].
The efficacy of treatments based on cognitive behavioral principles
was assessed in eleven RCTs (37%, 1370 patients) [38–48]. The
use of psychotropic drugs compared with placebo was evaluated in
seven RCTs (23%, 347 patients) [49–55]. Study quality was high
in 5 RCTs (17%) and acceptable in 25 (83%; Table S2). No
studies had to be excluded because of poor study quality. All
studies included in the systematic review but not in the meta-
analysis were rated to have low (n = 6) to no (n= 3) risk of outcome
reporting bias.
Treatment efficacy for NCCP due to gastroesophageal
reflux disease (GERD)
Only similar RCTs (n= 7, 771 patients) were included in the
meta-analysis (Figure 2). A PPI was administered in most RCTs
twice daily for 1 to 8 weeks. In two RCTs, GERD-positive and
GERD-negative patients were not distinguished [30,32]; in both of
these studies, the efficacy of treatment was more effective than
placebo. The pooled odds ratio for a reduction in chest pain of $
50% was 4.2 (95% CI 2.7 to 6.7, heterogeneity I2 = 26.6%).
When patients with GERD [n= 5, 192 patients, GERD-
positive: confirmed by upper endoscopy and/or 24-h pH
manometry [25–27,29,31]] were compared with patients without
GERD [n=4, 156 patients, GERD-negative [26,27,29,31]] the
treatment efficacy of the PPI treatment increased. The pooled OR
for GERD-positive patients with NCCP was 11.7 (95% CI 5.5 to
25.0, heterogeneity I2 = 6.1%); in comparison, the pooled OR for
patients without GERD was 0.8 (95% CI 0.2 to 2.8, heterogeneity
I2 = 50.4%).
While the heterogeneity among GERD-positive patients was
low and three of five RCTs emanated from the same center
[26,27,29], there was some heterogeneity among the GERD-
negative patients. Regarding GERD-negative patients, two RCTs
found a trend toward more chest pain in the treatment group
[26,27] while two RCTs found a trend toward less chest pain in
the PPI group [29,31]. Funnel plots for the three groups (GERD-
positive and GERD-negative mixed, GERD-positive alone, and
GERD-negative alone) are depicted in Figure S1. There was no
evidence for funnel plot asymmetry in the mixed group (GERD-
positive and GERD-negative, p = 0.27) or in the GERD-negative
group (p = 0.68); however, some evidence of funnel plot asymme-
try was observed in the GERD-positive group (p= 0.04), as
assessed using Egger’s regression test [22]. We refrained from
statistical adjustment for outcome reporting bias as proposed by
Copas et al. [19] because only one PPI treatment study was not
included in our meta-analysis [28]. Dore et al. did not analyze the
outcome of interest in our study and therefore the study was
associated with a low risk of outcome reporting bias (Table S3).
Jones et al. investigated the efficacy of hypnotherapy in patients
with functional gastrointestinal symptoms (Figure 2) [34]. Baclofen
treatment was associated with more chest pain (Figure 3) at the 2-
Figure 2. Efficacy of Proton Pump Inhibitor (PPI) treatment in patients with NCCP.
doi:10.1371/journal.pone.0104722.g002
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week follow-up [33]. Detailed results for all studies are summa-
rized in Table S4.
Treatment efficacy regarding the intensity and frequency
of non-cardiac chest pain
Treating patients with NCCP without a specific diagnosis of
psychiatric disease with the selective serotonin reuptake inhibitor
sertraline was more effective after 2 months [54], but not after 8
months of follow-up for chest pain intensity (Figure 3) [52].
Although use of the tricyclic antidepressant imipramine exhibited
a trend towards less chest pain intensity, the effect was not
statistically significant [49]. Findings were mixed regarding
treatments based on the principles of cognitive behavioral therapy
(CBT). One study showed that CBT (4 to 12 60-min sessions)
more effectively reduced chest pain intensity at 1 year than usual
care at the cardiology department [48]. Another study found that
cognitive skill training (5 bi-weekly and 6 30-min monthly
sessions), alone or supplemented with sertraline, was no more
effective than placebo or sertraline alone in reducing chest pain
intensity at 8 months of follow-up [52]. A brief CBT intervention
was not more effective in reducing chest pain intensity (Figure 3),
but more effectively reduced chest pain frequency (Figure 3) at 3
months of follow-up [39]. Two smaller RCTs found no [44] or
only a trend towards [41] less frequent chest pain after CBT
interventions (Figure 3). In a small pilot study Johrei, a process of
transmission of healing energy, was compared to a waiting list
[56]. While the treatment group experienced a significant
improvement in symptom intensity these findings need further
validation. The heterogeneity of the study settings and treatments
used prevented us from conducting a meta-analysis.
One study of patients with musculoskeletal NCCP found that
manipulation reduced pain more effectively than acupuncture and
Figure 3. Treatment efficacy in patients with NCCP: intensity and frequency of chest pain.
doi:10.1371/journal.pone.0104722.g003
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usual care (Figure 3) [35]. Another study found that chiropractic
treatment and home exercise were similarly effective [36]. The
pooled mean difference for the manipulation therapy was 0.5
(95% CI 20.3 to 1.3, heterogeneity I2 = 46.2%).
Efficacy of treatment regarding anxiety and depression
Only similar studies were included in meta-analyses. CBT more
effectively reduced anxiety scores in all studies (Figure 3). The
pooled mean difference for CBT in two similar studies [39,43] was
4.4 (95% CI 0.5 to 8.4, heterogeneity I2 = 32.7%).
CBT treatment reduced depression scores more effectively than
usual general practitioner (GP) care after 1 year [41,47]. The
pooled mean difference for CBT was 3.1 (95% CI 0.5 to 5.7,
heterogeneity I2 = 52.6%). A study with four arms compared CBT
or no treatment and sertraline or placebo [52]. While CBT with
and without sertraline was more effective at reducing anxiety
scores, they were no more effective at reducing depression scores
than placebo. At baseline, depression scores were lower than
anxiety scores in this study population (depression 8.9–10.2, range
0–63; anxiety 34–41, range 20–80).
Discussion
Main findings
The systematic analysis of 30 RCTs involving patients with
NCCP demonstrated that PPI treatment was effective in patients
with GERD. In NCCP patients without GERD, PPI treatment
was no more effective than placebo. Treatment based on cognitive
behavioral principles reduced chest pain frequency compared with
‘general practitioner treatment’ in three RCTs, while one study
found no effect. Most studies that compared the efficacy of
serotonin antagonists or tricyclic agents with placebo demonstrat-
ed no difference or only a trend towards less pain intensity in the
treatment arms. Manipulative treatment interventions produced
conflicting results for patients with musculoskeletal chest pain, and
acupuncture was no more effective than usual care. For most
prevalent diseases that manifested with chest pain, only a few
studies were available.
Results in light of the existing literature
To our knowledge, this is the first comprehensive systematic
review and meta-analysis to summarize the current evidence on
treatment efficacy based on RCTs for various diseases presenting
in patients with NCCP. Recently new therapies for NCCP of
gastrointestinal origin were discussed [57]. Treatment interven-
tions including nitrates, Phosphodiesterase-5 inhibitors, anticho-
linergics, calcium channel blockers, and endoscopic injection of
botulinum toxin may be effective in a subset of patients with
gastrointestinal diseases. Most of these interventions have been
studied in non-randomized trials or case series [58]. This
systematic review and meta-analysis confirms that limited RCTs
are available for many interventions and highlights the need for
further studies. Non-randomized trials tend to overestimate
treatment effects [59]. Further, this comprehensive overview
addresses the need for interdisciplinary evaluation and care in
patients with NCCP and summarizes the evidence for treatment
interventions in underlying diseases oftentimes not considered. A
recent systematic review found evidence that NCCP patients have
similar levels of psychological morbidity than patients with cardiac
chest pain and higher levels than healthy controls [60]. While
gastroesophageal diseases are common these findings indicate that
other diseases might not be diagnosed.
Only limited evidence was available for most prevalent diseases
that manifest with chest pain. Only two RCTs investigated
treatment efficacy of manual therapy in patients with musculo-
skeletal chest pain [35,36]. The efficacy of psychotropic drugs on
chest pain intensity, anxiety and depression scores were in line
with a recently published meta-analysis that analyzed the efficacy
of CBT compared with pharmacotherapy in adults with major
depressive disorder (21 RCTs, 2027 patients) or anxiety disorder
(21 RCTs, 1266 patients) [61]. The authors found CBT to be
equally effective as pharmacotherapy in patients with depression
whereas CBT was somewhat more effective than pharmacother-
apy in anxiety disorders [61]. It has been shown that patients
discharged from the emergency department with the diagnosis of
NCCP had elevated anxiety levels compared to healthy individuals
[62]. Anxiety disorder might be an underlying disease for subjects
with chest symptoms to seek evaluation in emergency depart-
ments. Interestingly, CBT was more effective in patients with
panic disorders [61]. This information may be relevant for further
management of patients with unexplained chest pain. No study
was identified that investigated panic disorders in patients with
NCCP. However, in patients that present with NCCP to the
emergency department, panic disorders are often not diagnosed
[63,64].
A recent meta-analysis using a hierarchical Bayesian model
demonstrated the diagnostic value of the response to high-dose
PPI treatment in patients with GERD [posterior mean sensitivity
0.89 and specificity of 0.88 [16]]. Together with the current
findings in patients with NCCP, in which GERD is suspected, PPI
treatment should be initiated early and PPI treatment response
should be evaluated after 2 weeks [16]. While the findings are in
line with previous published meta-analyses on PPI treatment
studies [65,66], this is the first meta-analysis to assess study quality
and the risk for outcome reporting bias. In comparison to Kahrilas
et al. [65,66] and Cremonini et al. [65,66], one additional study
was included [30]. Further, Cremonini et al. [65,66] included
open-label studies and did not distinguish between GERD-positive
and GERD-negative patients. We also used odds ratios as the
effect measure for pooling because of its favorable mathematical
properties over the relative risk. This includes that the odds ratio is
unbounded regardless of the underlying event rate [67]. Our study
expands on a relevant aspect in the clinical setting where the PPI
response is often used for the diagnosis of GERD. We showed that
the effect in a mixed patient sample is smaller compared to
patients where GERD was diagnosed by a reference test (e.g. 24-
hour pH monitoring). Therefore, a lack of response to PPI
treatment after 2 weeks should lead to discontinuation of PPI
treatment, while a response indicates underlying GERD for which
PPI treatment is effective.
Strengths and limitations
This review comprehensively evaluates the currently available
studies. The search was inclusive; no language restrictions were
applied, a thorough bibliographic search was conducted to identify
all relevant studies, and rigorous methodology was applied. The
extraction process was performed in accordance with current
guidelines and supported by an experienced statistician. Potential
factors influencing treatment efficacy were identified by a
multidisciplinary team (an internist, general practitioner, statisti-
cian, and methodologist).
The main limitation of this systematic review and meta-analysis
was the limited number of RCTs. Many interventions used in
clinical practice in patients with NCCP were not assessed in
RCTs. Of the included studies, many were only of moderate
methodological quality. Furthermore, NCCP is a collective term
with potentially different underlying diseases and therefore might
present differently. Treatment efficacy in one population in which
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the prevalence for one disease is high might be entirely different
for another population [68]. In addition, the heterogeneity of the
outcome measures used and follow-up durations reported
prevented us from including most studies in our meta-analysis.
The results of these studies should be interpreted on an individual
study level within the context of the study population. We have
tried to balance this by providing a thorough description of the
studies inclusion and exclusion criteria and the study settings. This
information will allow readers to judge to whom various study
results apply.
Research implications
Additional research should compare diagnostic indicators (e.g.,
pain increase with movement or decrease on medication were
associated with musculoskeletal chest pain) [16] plus a corre-
sponding treatment intervention to usual care alone in defined
patient populations (e.g., emergency departments, primary care).
Future research should also aim to contribute to our knowledge
about diagnostic processes and treatment decisions for patients
with NCCP. Although most patients with chest pain consult
primary care physicians [69], few studies are performed in this
setting. Additional research is needed to strengthen the evidence in
a primary care setting. Screening questionnaires for panic and
anxiety disorders could be used to identify patients that need
further specialized assessment and would respond well to
treatments based on cognitive behavioral principles. No such
study was found in the current analysis.
Implication for practice
Patients with NCCP incur high healthcare costs owing to
extensive and often invasive diagnostic testing, as well as the effect
of NCCP on quality of life. Early identification of underlying
diseases is essential to avoid delayed treatment and chronicity of
complaints. Symptoms and clinical findings may provide impor-
tant information to guide treatment of an underlying illness [16].
In patients with typical GERD symptoms, twice-daily high-dose
PPI treatment is the most efficient diagnostic and therapeutic
approach. GERD is very likely if a positive treatment response
occurs after 1 week, and is unlikely if there is no response after 4
weeks of PPI treatment [16]. In patients that do not respond to
PPI, PPI treatment should be stopped if an endoscopy reveals no
pathological findings.
Panic and anxiety disorders are often missed in clinical practice
[70]. For patients with anxiety, treatments based on cognitive
behavioral principles might be more effective than pharmacologic
treatment. To date, evidence for the efficacy of serotonin
antagonists or tricyclic agents in patients with NCCP is weak.
Conclusion
Timely diagnostic evaluation and treatment of the underlying
disease is important for patients with NCCP. The current
systematic review and meta-analysis showed a lack of RCTs for
many diseases presenting with NCCP or treatment interventions
proposed in the literature. Only limited evidence was available for
prevalent diseases that manifest with chest pain. In addition, many
treatment interventions that have been shown to be effective in
non-randomized trials have not been studied in RCTs and might
overestimate treatment efficacy. In patients suspected to have
GERD high-dose treatment with a PPI is effective. In otherwise
unexplained NCCP treatments based on cognitive behavioral
principles might be considered. There is a need for further high
quality studies addressing the gaps highlighted in this review.
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